Concentration of platelets and growth factors in canine autologous conditioned plasma

M. Stief; J. Gottschalk; J.-C. Ionita; A. Einspanier; G. Oechtering; P. Böttcher

doi:10.3415/VCOT-10-04-0064

Veterinary and Comparative Orthopaedics and Traumatology, Table of Contents

Vet Comp Orthop Traumatol 2011; 24(02): 122-125
DOI: 10.3415/VCOT-10-04-0064

Original Research

Schattauer GmbH

Concentration of platelets and growth factors in canine autologous conditioned plasma

M. Stief

¹Department of Small Animal Medicine, University of Leipzig, Leipzig, Germany

,

J. Gottschalk

²Institute of Physiological Chemistry, University of Leipzig, Leipzig, Germany

,

J.-C. Ionita

³Large Animal Clinic for Surgery, University of Leipzig, Leipzig, Germany

,

A. Einspanier

²Institute of Physiological Chemistry, University of Leipzig, Leipzig, Germany

,

G. Oechtering

¹Department of Small Animal Medicine, University of Leipzig, Leipzig, Germany

,

P. Böttcher

¹Department of Small Animal Medicine, University of Leipzig, Leipzig, Germany

› Author Affiliations

Abstract

Summary

Objectives: To report the concentration of blood cells and selected growth factors in canine autologous conditioned plasma (ACP).

Methods: The density of blood cells in whole blood (WB), ACP and standard plasma preparation (SP) of 10 healthy mature dogs was determined. In both ACP and SP, the concentration of insulin-like growth factor-1 (IGF-1), epidermal growth factor, vascular endothelial growth factor, platelet-derived growth factor-AA, platelet-derived growth factor-AB, platelet-derived growth factor-BB, transforming growth factor-β1 (TGF-β1), and transforming growth factor-β2 was measured using the ELISA technique. In another ten dogs, ACP was prepared using an ultra-soft spinning protocol, and again blood cell density was compared to that obtained in WB.

Results: The density of platelets in ACP was significantly higher than that in SP (p = 0.0002), but there was not any significant difference between ACP and WB, nor between WB and ACP prepared using softer centrifugations. Interestingly, only for IGF-1, PDGFBB, and TGF-β1 could reliable measurements be obtained, showing a significant increase in PDGF-BB and TGF-β1 concentrations in ACP compared to SP (p = 0.001, p = 0.0028). Regarding IGF-1 content, there was not any significant difference between ACP and SP.

Clinical significance: Canine ACP prepared according to the manufacturer’s recommendations, or by using a softer spin does not show the same specifications as human ACP, which shows a doubling in platelet count compared to WB. Even though canine ACP has a similar number of platelets per injected volume and consequently, probably the same amount of injected growth factors than WB, application of canine ACP would not be associated with the proinflammatory potential reported for WB, as it is almost free of erythrocytes and nucleated cells.

Keywords

Platelet-rich plasma - dog - thrombocyte - growth factor

Full Text

References

References
1 Sanchez M, Anitua E, Orive G. et al. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med 2009; 39: 345-354.
2 Waselau M, Sutter WW, Genovese RL. et al. Intralesional injection of platelet-rich plasma followed by controlled exercise for treatment of mid-body suspensory ligament desmitis in Standard-bred racehorses. J Am Vet Med Assoc 2008; 232: 1515-1520.
3 Bosch G, Rene van Weeren P, Barneveld A. et al. Computerised analysis of standardised ultra-sonographic images to monitor the repair of surgically created core lesions in equine superficial digital flexor tendons following treatment with intratendinous platelet rich plasma or placebo. Vet J 2010; 187: 92-98.
4 Hauschild G, Merten HA, Bader A. et al. Bioartificial bone grafting: Tarsal joint fusion in a dog using a bioartificial composite bone graft consisting of beta-tricalciumphosphate and platelet rich plasma--a case report. Vet Comp Orthop Traumatol 2005; 18: 52-54.
5 Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent 2001; 10: 225-228.
6 Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg 2005; 16: 1043-1054.
7 Alsousou J, Thompson M, Hulley P. et al. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 2009; 91: 987-996.
8 Weibric G, Buch RS, Kleis WK. et al. Quantification of thrombocyte growth factors in platelet concentrates produced by discontinuous cell separation. Growth Factors 2002; 20: 93-97.
9 Saito M, Takahashi KA, Arai Y. et al. Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clin Exp Rheumatol 2009; 27: 201-207.
10 Akeda K, An HS, Okuma M. et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage 2006; 14: 1272-1280.
11 Buhr M, Siekmann W. Intraarticular injection of platelet rich plasma for cartilage repair. Orthopädische Praxis 2009; 45: 10-16.
12 Kon E, Buda R, Filardo G. et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 2009; 18: 472-479.
13 Sanchez M, Anitua E, Azofra J. et al. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol 2008; 26: 910-913.
14 Frisbie DD, Kawcak CE, Werpy NM. et al. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res 2007; 68: 290-296.
15 Carmona JU, Arguelles D, Climent F. et al. Report of the intraarticular treatment with platelet rich plasma in 7 horses with joint disease. Proceedinvs of the 14th Annual Scientific Meeting of European College of Veterinary Surgeons 2005. July 7-9 Lyon; France: 68-71.
16 Buhr M, Siekmann W. Intra-articular injection of thrombocyte-enriched plasma for the treatment of cartilage damage. A clinical observation study [White Paper]. Naples (FL, USA): Arthrex Inc; 2007
17 Clemmons RM, Bliss EL, Dorsey-Lee MR. et al. Platelet function, size and yield in whole blood and in platelet-rich plasma prepared using differing centrifugation force and time in domestic and food-producing animals. Thromb Haemost 1983; 50: 838-843.
18 Van Wie BJ, Hustvedt EL. Particle interaction effects on blood cell sedimentation and separations. Biorheology 1988; 25: 651-662.
19 Perotta PL, Snyder EL. Platelet storage and trans-fusion. In: Michelson A. editor Platelets. 2 edition. Burlington (MA, USA): Academic Press; 2007: 1265-1295.
20 Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 2004; 114: 1502-1508.
21 Rubin R, Baserga R. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest 1995; 73: 311-331.
22 Jansen NW, Roosendaal G, Wenting MJ. et al. Very rapid clearance after a joint bleed in the canine knee cannot prevent adverse effects on cartilage and synovial tissue. Osteoarthritis Cartilage 2009; 17: 433-440.